[37] ooo1, Myunggeun Oh1, Seung-Kyoon Kim* , Geun-Woo Kim* (Corresponding*), enhancer RNA regualatory mechanism in HBV
[36] ooo1, Myunggeun Oh1, Seung-Kyoon Kim* , Geun-Woo Kim* (Corresponding*), enhancer RNA degradation mechanism in ESC
[35] ooo1, Myunggeun Oh1, Jiin Moon, Seung-Kyoon Kim* (Corresponding*), Nuclear miRNAs form condensates with TDP-43, FASEB JOURNAL, 2026 Manuscript in Preparation.
[34] Jiin Moon1, Myunggeun Oh, Hyohi Lee, Seung-Kyoon Kim* (Corresponding*), Functional dynamics of let-7 miRNA family in ESCs in neurons. Genome Biol or Nucleic Acids Res or Stem Cell Res Ther, 2025 Manuscript in Preparation.
[33] Myunggeun Oh1, Hyohi Lee1, Seung-Kyoon Kim* (Corresponding*), Functional dynamics of let-7 miRNA family in ESCs. Genome Biol or Nucleic Acids Res or Stem Cell Res Ther, 2026 Manuscript in Preparation.
[32] Hyohi Lee1, Myunggeun Oh1, Jiin Moon, Seung-Kyoon Kim* (Corresponding*), Nuclear miRNAs form condensates with LIN28a in nucleoli, Cell Stem Cell, 2026 Manuscript in Preparation.
[31] Myunggeun Oh1, Hyohi Lee, Seung-Kyoon Kim* (Corresponding*), Arc eRNA in ESC. Genome Biol or Nucleic Acids Res or Stem Cell Res Ther, 2026 Manuscript in Preparation.
[30] Hyohi Lee1, Myunggeun Oh1, Seung-Kyoon Kim* (Corresponding*), Analysis of miRNA types related to degradation in ESC. Genome Biol or Nucleic Acids Res, 2026 Manuscript in Preparation.
[29] Hyohi Lee1, Myunggeun Oh1, Seung-Kyoon Kim* (Corresponding*), Identification of active miRNA TSSs reveals novel regulatory mechanisms in ESCs (mi-eRNA). BMC Biol or Nucleic Acids Res, 2026 Manuscript in Preparation.
[28] Jiin Moon, Myunggeun Oh, Hyohi Lee, Seung-Kyoon Kim* (Corresponding*), Functional regulation of METTL5 by enhancer RNA.
International Journal of Stem Cells, 2025 Manuscript in Preparation.
[27] Seunghwa Jeong1, Jiin Moon, Myunggeun Oh, Hyohi Lee, Seung-Kyoon Kim* (Corresponding*), Functional regulation of METTL3/14 by enhancer RNA.
World Journal of Stem Cells, 2025 Manuscript in Preparation.
[26] Seunghwa Jeong1, Hyohi Lee1, Seung-Kyoon Kim* (Corresponding*), [Review] Identification of active miRNA TSSs, dREG
multiple enhancer가 생성되는 과정. ESC에서 super enhancer 인 것이 전체적으로 없어지고, 일부가 남은거. 기능적으로 각각이 time course 하게 유전자 조절. 예) Slc2a3
[27] Seunghwa Jeong1, Hyohi Lee, Seung-Kyoon Kim* (Corresponding*), Enhancer RNA degradation in ESC. 2025 Manuscript in Preparation.
[26] Seunghwa Jeong1, Myunggeun Oh, Hyohi Lee, Seung-Kyoon Kim* (Corresponding*), Functional regulation of DCP2 through enhancer RNA in ESC. 2025 Manuscript in Preparation.
[22] Jiin Moon1, Hyohi Lee1, Myunggeun Oh, Seung-Kyoon Kim* (Corresponding*), Nsun2 and Pus7 Cross-talk (다른 RNA mod. 와의 상호작용).
Nucleic Acids Res, 2025 Manuscript in Preparation.
[24] Seunghwa Jeong1, Myunggeun Oh1, Seung-Kyoon Kim* (Corresponding*), Compare Enhancer Transcripts from Intergenic and Intragenic Regulatory Elements 이거? active, poised, primed 비교?. J Vis Exp [JoVE]. Under Revision, 2025 (IF: 1.00/ 5Y IF: 1.3, 상위 62.60%), 사사: 신진, 차세대
[23] SJ Oh, Seung-Kyoon Kim* (Corresponding*), Lentiviral-based RNAi System for Efficient Depletion of Enhancer RNA in Mouse Embryonic Stem Cells. Manuscript in Preparation, 2025
[22] Hyohi Lee1, Jiin Moon1, Seung-Jin Kim, Jaehyun Yang, Jaeil Han*, Seung-Kyoon Kim* (Corresponding*), Lin28a eRNA-mediated regulation of NPC differentiation (NPC 때 Lin28a 는 거의 없어지는데, eRNA는 ESC 에서와 비슷한 수준으로 유지됨. 이 eRNA의 기능.).
Submitted. Genes & Genomics, 2025
[25] Myunggeun Oh1, Hyohi Lee1, Dahun Um1, Tae-Kyung Kim*, Seung-Kyoon Kim* (Corresponding*), Identification of active miRNA TSSs reveals novel regulatory mechanisms in neurons. Nucleic Acids Res or Genome Biol, 2025 Manuscript in Preparation.
[23] Hyohi Lee1, Jiin Moon1, Seunghwa Jeong, Myunggeun Oh, Seung-Kyoon Kim* (Corresponding*), Lin28b-mediated regulation of differentiation through enhancer selection (antisense intragenic eRNAs의 기능 강조).
Nucleic Acids Res or Cell Mol Biol Lett, 2025 Manuscript in Preparation.
[26] Hyohi Lee,, Seung-Kyoon Kim* (Corresponding*), [Review] Non-coding RNA-Guided Assembly of Transcriptional Condensates in Pluripotency. Cells, 2025 Manuscript in Preparation. 2025 말에 투고
[30] Myunggeun Oh1, Hyohi Lee, Seunghwa Jeong, Seung-Kyoon Kim* (Corresponding*), Systematic analysis of genomic features defining LIN28A-bound enhancer function.
Nucleic Acids Res or Genome Biol., 2025
[24] Seunghwa Jeong1, Dahun Um1, Myunggeun Oh1, Tae-Kyung Kim*, Seung-Kyoon Kim* (Corresponding*), Hybrid enhancer; Profiling of dynamic enhancer sets depending on representative pluripotency factors in mESC.
2025. Cell Mol Biol Lett or Int J Biol Macromol, 사사: 신진, 차세대
[27] Jiin Moon1, Hyohi Lee1, Myunggeun Oh1, Seunghwa Jeong, Seung-Kyoon Kim* (Corresponding*), Enhancer-Mediated Regulation of PUS7 and Its Pseudouridylation of Nsun2 eRNA in Pluripotency and Early Differentiation.
J Adv Res or Cell Mol Biol Lett or Int J Biol Macromol, 2026 Under Revision.
[28] Hyohi Lee1, Myunggeun Oh1, Jiin Moon1, Yeonju Jang, Minhee Lee, Dahun Um, Daeyoup Lee, Tae-Kyung Kim, Seung-Kyoon Kim* (Corresponding*), Temporal logic of multiple eRNAs orchestrates stem cell fate in response to extrinsic stimuli.
Nucleic Acids Res, 2025 (IF: 13.10/ 5Y IF: 16.8, 상위 4.30%), 사사: 신진, 차세대
[27] Hyohi Lee1, Jiin Moon, Seung-Kyoon Kim* (Corresponding*), Protocol for entiviral RNAi-mediated depletion of enhancer RNAs in mESCs.
Star Protocol, 2026 Submitted. (IF: 1.3/ 5Y IF: 1.7, 상위 89.00%), 사사: 신진, 차세대
[24] Myunggeun Oh1, Dahun Um2, Seunghwa Jeong1, Tae-Kyung Kim2,*, Seung-Kyoon Kim1,* (Corresponding*), Compare Enhancer Transcripts from Intergenic and Intragenic Regulatory Elements 이거? active, poised, primed 비교.
FASEB JOURNAL. Int J Biol Macromol. Under Revision, 2025 (IF: 1.00/ 5Y IF: 1.3, 상위 62.60%), 사사: 신진, 차세대
[23] Yeonju Jang1, Hyohi Lee1, Myunggeun Oh, Jiin Moon, Seung-Jin Kim, Jong-yeol Park*, Seung-Kyoon Kim* (Corresponding*), Enhancer RNA-driven regulation of TDP-43 guides pluripotency and neural lineage transitions.
Anim Cells Syst, 2025 (IF: 3.20/ 5Y IF: 2.50, 상위 4.70%) or , 사사: 신진, 차세대
[20] Hyohi Lee1, Jiin Moon, Seung-Kyoon Kim* (Corresponding*), Lentiviral RNAi-mediated depletion of enhancer RNAs in primary neurons.
Methods Mol Biol, Under Revision (Invited), 2025 (Scopus), 사사: 재직 II [2024-0991-01 (S.-K.K.)], 신진, 차세대. => 재직 II 를 두 개에 해두고, 이걸로 가능하다고 하면, 이걸로. 공동 사사 가능.
[22] Myunggeun Oh1, Seunghwa Jeong1, Jae-Hyun Yang*, Seung-Kyoon Kim* (Corresponding*), Enhancer Architecture and Spatial Logic of Lineage Specification.
Cells, 2026 Under Review (Invited), (IF: 5.20/ 5Y IF: 6.10, 상위 28.70%, Q2), 사사: 신진, 차세대, 양재현 교수님 신진
[23] Jinsung Lee1, SeungA Cho1, Seung-Kyoon Kim*, Jae-Hyun Yang* (Corresponding*), Epigenetic aging and rejuvenation of the brain: drivers, consequences, and interventions.
BMB Reports, 2026 In Press (Invited) [DOI: 10.] (IF: 3.3/ 5Y IF: 3.5, 상위 44.8%, Q2) [ISSN: 1976-6696] 사사: 차세대
[21] Myunggeun Oh1, Seunghwa Jeong1, Keunsoo Kang*, Seung-Kyoon Kim* (Corresponding*), [Review] Enhancer Trajectories in Lineage Commitment: Regulatory Logic of States and Cooperation.
Biomolecules. 2025. Under Review (Invited), (IF: 4.80/ 5Y IF: 5.60, 상위 23.40%, Q1), 사사: 신진, 차세대
[22] Hyohi Lee1, Jiin Moon1, Yeonju Jang, Seung-Kyoon Kim* (Corresponding*), [Review] RNAa-Mediated Gene Activation in the Regulation of Pluripotency.
Biomolecules. 2025. Under Review (Invited), (IF: 4.80/ 5Y IF: 5.60, 상위 23.40%, Q1), 사사: 신진, 차세대
[19] Jiin Moon, Hyohi Lee, Yeonju Jang, Seung-Kyoon Kim* (Corresponding*), Optimized Quantitative Assessment of Enhancer RNA Stability in Mouse Embryonic Stem Cells.
J Vis Exp [JoVE], Under Revision, 2025. Under Revision (IF: 1.00/ 5Y IF: 1.3, 상위 62.60%), 사사: 재직 II [2024-0991-01 (S.-K.K.)], 신진, 차세대. 공동 사사 가능.
[18] Myunggeun Oh1, Seunghwa Jeong1, Seung-Kyoon Kim* (Corresponding*), Genome-Wide Identification and Quantification of Enhancer Transcripts from Intergenic and Intragenic Regulatory Elements.
J Vis Exp [JoVE], Accepted (Invited), 2025 (IF: 1.00/ 5Y IF: 1.3, 상위 62.60%), 사사: 자체연구-신임교원 [2022-0582-01 (S.-K.K.) and 2023-0545-01 (S.-K.K.) 단독 사사 (2개 논문을 자체연구의 사사로 사용으면 2개 모두 우수논문게재장려금을 못 받으니, 이 논문만 단독 사사 하는게 나음)
[17] Seunghwa Jeong1, Myunggeun Oh1, Jaeil Han*, Seung-Kyoon Kim* (Corresponding*), [Review] RNA Degradation in Pluripotent Stem Cells: Mechanisms, Crosstalk, and Fate Regulation. Cells, 2025 Oct 20; 14(20), 1634 (IF: 5.20/ 5Y IF: 6.10, 상위 28.70%, Q2), 사사: 한우물 (재일), 신진, 차세대
[16] Jiin Moon1, Hyohi Lee1, Yeonju Jang, Seung-Kyoon Kim* (Corresponding*), [Review] NSUN-Mediated m5C RNA Modification in Stem Cell Regulation.
Cells, 2025 Oct 16; 14(20), 1609 (IF: 5.20/ 5Y IF: 6.10, 상위 28.70%, Q2) , 사사: 신진, 차세대
[15] Jiin Moon1, Hyohi Lee1, Myunggeun Oh, Yeonju Jang, Dahun Um, Tae-Kyung Kim, Seung-Kyoon Kim* (Corresponding*), Embryonic stem cell-specific intragenic enhancer RNA essential for NSUN2-mediated stem cell fate regulation.
Int J Biol Macromol [BIOMAC]. 2025 (IF: 8.50/ 5Y IF: 8.70, 상위 5.90%), 사사: 신진, 최초혁신, 차세대, 자체연구-신임교원 [2022-0582-01 (S.-K.K.) and 2023-0545-01 (S.-K.K.)]-이거 사사하면 우수논문게재장려금을 못받으니까, 이 논문으로 사사 사용 안함.
This study was supported by
the research fund of Chungnam National University [2024-0991-01 (S.-K.K.)];
the Bio&Medical Technology Development Program [RS-2025-02305916 (S.-K.K.)] and
the Basic Science Research Program [RS-2023-00209842 (S.-K.K.)] of the National Research Foundation (NRF) funded by the Korean government (MSIT).